You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 51 No. 12, December 1994 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Contributions
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Lower Cognitive Performance in Normal Older Adult Male Twins Carrying the Apolipoprotein E {varepsilon}4 Allele

Terry Reed, PhD; Dorit Carmelli, PhD; Gary E. Swan, PhD; John C. S. Breitner, MD; Kathleen A. Welsh, PhD; Gail P. Jarvik, MD; Samir Deeb, PhD; Johan Auwerx, MD

Arch Neurol. 1994;51(12):1189-1192.


Abstract

Objective
Given the strong association of the apolipoprotein E (apoE) allele {varepsilon}4 with late-onset Alzheimer dementia or multi-infarct dementia, we tested whether normal older adult men with at least one {varepsilon}4 allele demonstrate subclinical changes in cognition and perform more poorly on tests of cognitive function compared with subjects without the {varepsilon}4 allele.

Design
Matched-pair design of normal adult male (average age, 63 years) fraternal twins.

Setting
Subjects voluntarily participated on an outpatient basis at a research or medical center facility.

Participants
Members of the National Heart, Lung, and Blood Institute twin panel third examination previously genotyped for apoE.

Main Outcome Measure
Education-adjusted scores on several neuropsychological tests were compared in twins discordant for the apoE {varepsilon}4 allele. Subjects with documented cerebrovascular disease were excluded.

Results
Among 20 fraternal twin pairs discordant for the presence of {varepsilon}4, twins with the {varepsilon}4 allele demonstrated poorer mean performance than their co-twins without the {varepsilon}4 allele. This relationship was also noted crosssectionally where age- and education-adjusted scores of 50 individual twin subjects with at least one {varepsilon}4 allele demonstrated poorer performance compared with 138 individual twins without an {varepsilon}4 allele.

Conclusions
The apoE {varepsilon}4 allele may be associated with decreased cognitive function in discordant twin pairs. Our results suggest that {varepsilon}4 may represent a potential marker for accelerated cognitive aging and such individuals may be at greater risk for development of late-onset Alzheimer dementia or multi-infarct dementia.



Author Affiliations

From the Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis (Dr Reed); Health Sciences Program, SRI International (formerly Stanford Research Institute), Menlo Park, Calif (Drs Carmelli and Swan); Department of Psychiatry and the Joseph and Kathleen Bryan Alzheimer's Disease Research Center, Duke University Medical Center, Durham, NC (Drs Breitner and Welsh); Division of Medical Genetics, Department of Medicine, University of Washington Medical Center, Seattle (Drs Jarvik and Deeb); and Laboratoire de Biologie des Régulations chez les Eucaryotes, Institut Pasteur, Lille, France (Dr Auwerx).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Performance on Neurocognitive Tests by Co-twins to Dementia Cases Compared to Normal Control Twins
Gatz et al.
J Geriatr Psychiatry Neurol 2005;18:202-207.
ABSTRACT  

Association of sex steroid hormones with brain morphology and cognition in healthy elderly men
Lessov-Schlaggar et al.
Neurology 2005;65:1591-1596.
ABSTRACT | FULL TEXT  

MMSE Items Predict Cognitive Decline in Persons with Genetic Risk for Alzheimer's Disease
Ercoli et al.
J Geriatr Psychiatry Neurol 2003;16:67-73.
ABSTRACT  

The role of APOE-{epsilon}4 in longitudinal cognitive decline: MacArthur Studies of Successful Aging
Bretsky et al.
Neurology 2003;60:1077-1081.
ABSTRACT | FULL TEXT  

Alzheimer's disease can be accurately diagnosed in very mildly impaired individuals
Salmon et al.
Neurology 2002;59:1022-1028.
ABSTRACT | FULL TEXT  

The Apolipoprotein E {epsilon}4 Allele and Decline in Different Cognitive Systems During a 6-Year Period
Wilson et al.
Arch Neurol 2002;59:1154-1160.
ABSTRACT | FULL TEXT  

Androgens Protect against Apolipoprotein E4-Induced Cognitive Deficits
Raber et al.
J. Neurosci. 2002;22:5204-5209.
ABSTRACT | FULL TEXT  

Memory decline in healthy older people: Implications for identifying mild cognitive impairment
Collie et al.
Neurology 2001;56:1533-1538.
ABSTRACT | FULL TEXT  

Prominent Axonopathy and Disruption of Axonal Transport in Transgenic Mice Expressing Human Apolipoprotein E4 in Neurons of Brain and Spinal Cord
Tesseur et al.
Am. J. Pathol. 2000;157:1495-1510.
ABSTRACT | FULL TEXT  

Cognitive Function and Apolipoprotein E in Very Old Adults: Findings From the Nun Study
Riley et al.
Journals of Gerontology Series B: Psychological Sciences and Social Science 2000;55:69S-75.
ABSTRACT | FULL TEXT  

Expression of Human Apolipoprotein E4 in Neurons Causes Hyperphosphorylation of Protein Tau in the Brains of Transgenic Mice
Tesseur et al.
Am. J. Pathol. 2000;156:951-964.
ABSTRACT | FULL TEXT  

APOE {epsilon}4 does not predict mortality, cognitive decline, or dementia in the oldest old
Juva et al.
Neurology 2000;54:412-412.
ABSTRACT | FULL TEXT  

Preclinical memory decline in cognitively normal apolipoprotein E-{epsilon}4 homozygotes
Caselli et al.
Neurology 1999;53:201-201.
ABSTRACT | FULL TEXT  

Specific Regional Transcription of Apolipoprotein E in Human Brain Neurons
Xu et al.
Am. J. Pathol. 1999;154:601-611.
ABSTRACT | FULL TEXT  

Isoform-specific effects of human apolipoprotein E on brain function revealed in ApoE knockout mice: Increased susceptibility of females
Raber et al.
Proc. Natl. Acad. Sci. USA 1998;95:10914-10919.
ABSTRACT | FULL TEXT  

Apolipoprotein E {epsilon}4 Allele and Whole Brain Atrophy in Late-Onset Alzheimer's Disease
Yasuda et al.
Am. J. Psychiatry 1998;155:779-784.
ABSTRACT | FULL TEXT  

Longitudinal SPECT study in Alzheimer's disease: relation to apolipoprotein E polymorphism
Lehtovirta et al.
J. Neurol. Neurosurg. Psychiatry 1998;64:742-746.
ABSTRACT | FULL TEXT  

Relationship Between ApoE, MRI Findings, and Cognitive Function in the Cardiovascular Health Study
Kuller et al.
Stroke 1998;29:388-398.
ABSTRACT | FULL TEXT  

Apolipoprotein E Phenotype and Cognitive Decline in a Prospective Study of Elderly Community Women
Yaffe et al.
Arch Neurol 1997;54:1110-1114.
ABSTRACT  

Cerebrovascular Disease, the Apolipoprotein e4 Allele, and Cognitive Decline in a Community-Based Study of Elderly Men
Kalmijn et al.
Stroke 1996;27:2230-2235.
ABSTRACT | FULL TEXT  

Apolipoprotein E Genotype Determines Survival in the Oldest Old (85 Years or Older) Who Have Good Cognition
Corder et al.
Arch Neurol 1996;53:418-422.
ABSTRACT  

Apolipoprotein E: Emerging Story in the Pathogenesis of Alzheimer's Disease
Strittmatter and Roses
Neuroscientist 1995;1:298-306.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1994 American Medical Association. All Rights Reserved.